Comprehensive description of adult-onset Still's disease after COVID-19 vaccination-Reference-Cited by-同舟云学术

Comprehensive description of adult-onset Still's disease after COVID-19 vaccination

Published:2023-01 Issue: Volume:134 Page:102980
ISSN:0896-8411
Container-title:Journal of Autoimmunity
language:en
Short-container-title:Journal of Autoimmunity

Author:

Palassin Pascale^ORCID,Bres Virginie,Hassan Samaher,Alfonsi Ange,Massy Nathalie,Gras-Champel Valérie,Maria Alexandre Thibault Jacques,Faillie Jean-Luc

Funder

Agence Nationale de Sécurité du Médicament et des Produits de Santé

Publisher

Elsevier BV

Subject

Immunology,Immunology and Allergy

Reference55 articles.

1. French organization for the pharmacovigilance of COVID-19 vaccines: a major challenge;Lacroix;Therapie,2021

2. Thrombotic thrombocytopenia after ChAdOx1 nCov-19 vaccination;Greinacher;N. Engl. J. Med.,2021

3. Safety of the BNT162b2 mRNA covid-19 vaccine in a nationwide setting;Barda;N. Engl. J. Med.,2021

4. COVID-19: consider cytokine storm syndromes and immunosuppression;Mehta;Lancet Lond. Engl.,2020

5. Autoimmune post-COVID vaccine syndromes: does the spectrum of autoimmune/inflammatory syndrome expand?;Jara;Clin. Rheumatol.,2022

Cited by 6 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Réaction auto-inflammatoire type maladie de Still induite par le nivolumab;Bulletin du Cancer;2024-09

2. Adult-onset Still’s disease following severe acute respiratory syndrome coronavirus 2 vaccination presenting with persistent psoriasis-like dermatitis: A case report;Dermatologica Sinica;2024-02-23

3. Role and Responsibilities of Various Stakeholders in Pharmacovigilance (PV);Current Drug Safety;2024-02-02

4. Recent advances and evolving concepts in Still’s disease;Nature Reviews Rheumatology;2024-01-11

5. Characteristics of COVID-19 and Impact of Disease Activity in Patients with Adult-Onset Still’s Disease;Rheumatology and Therapy;2024-01-06